biotech

Showing 15 posts of 841 posts found.

6.5% pay rise agreed for NHS staff

June 8, 2018
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

After years of receiving only a 1% annual pay rise, NHS staff have voted to accept a 6.5% pay offer increase …

pfizer_chrome_plate

Pfizer successfully appeals 2,600% price hiking case

June 8, 2018
Medical Communications Flynn Pharma, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer and co-defendant Flynn Pharma have won their appeal against a £90 million fine imposed on them by the Competition …

Bill Gates backed biotech reveals strategy

June 8, 2018
Medical Communications Bill and Melinda Gates Foundation, biotech, drugs, pharma, pharmaceutical

The Bill and Melina Gates Foundation already funnels a large amount of money into aiding public health, particularly by funding …

cancer_research_uk

Cancer Research UK unveil new Chief Business Officer

June 8, 2018
Medical Communications Cancer Research UK, biotech, drugs, pharma, pharmaceutical

Cancer Research UK has appointed Tony Hickson to the position of Chief Business Officer. He arrives to the business from …

nerves

Parkinson’s disease: A quest for steadier therapies

June 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Parkinson's disease, biotech, drugs, pharma, pharmaceutical

The worrying number of deaths associated with Nuplazid has eyes returning to the pipeline for Parkinson’s disease. Anjali Shukla, a …

J&J looks to trim business with $2.8bn sale

June 7, 2018
Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

Johnson & Johnson continues to look at options to slim down its business, after having received an offer from Fortive …

Pfizer pumps $600m into venture fund, targeting neuroscience

June 7, 2018
Research and Development, Sales and Marketing Pfizer, biotech, drugs, neuroscience, pharma, pharmaceutical

Pfizer’s move to dump its neuroscience divisions caused serious ripples through the industry, with many wondering whether it heralded an …

money-2180330_960_720

Forty Seven springs out of the blocks ahead of IPO

June 7, 2018
Research and Development, Sales and Marketing Forty Seven, biotech, drugs, pharma, pharmaceutical

Forty Seven, a spinout from Stanford University, has had a busy few days – first announcing that it had filed …

handshake2

Axovant attempts to rise from ashes with $842m Parkinson’s therapy deal

June 7, 2018
Sales and Marketing Axovant, Oxford BioMedica, biotech, drugs, pharma, pharmaceutical

Axovant’s spectacular crash to Earth, after a soaring IPO that saw its share price hit the heady heights of $26, …

FlyPharma Conference Europe concludes its fourth successful year in Brussels

June 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, flypharma, pharma, pharmaceutical

The FlyPharma Conference Europe wrapped up for another year on 6 June, returning with an expanded roster of speakers who …

diana-bracco-100-01

Milan’s decision to appeal the EMA HQ relocation explained

June 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Milan, biotech, drugs, pharma, pharmaceutical

The decision to award the EMA headquarters to Amsterdam was a contentious one, not least because the vote had to …

novartis_side_building

Amgen/Novartis migraine med gets CHMP nod

June 4, 2018
Sales and Marketing Aimovig, Amgen, Novartis, biotech, drugs, pharma, pharmaceutical

Amgen and Novartis have announced that their newly FDA-approved treatment for migraines has received a recommendation from the CHMP, generally …

doctor_notes

Keytruda offers significant hope in subset of prostate cancer

June 4, 2018
Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, prostate cancer

Up until present, no studies had shown that immunotherapies could offer potential treatment for men with prostate cancer; however, at …

onlinr

Celgene bring in new CFO to steady the ship

June 4, 2018
Medical Communications, Sales and Marketing Celgene, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …

bayer_cross_2

Bayer eyes R&D cuts, as Monsanto deal raises question of focus

June 1, 2018
Medical Communications Bayer, biotech, drugs, monsanto, pharma, pharmaceutical

When rumours first started rumbling about a mega-merger between Bayer and Monsanto, one of the major question marks was on …

Latest content